ConditionCancer

Peritoneal Carcinomatosis (Peritoneal Metastases)

Peritoneal carcinomatosis is the spread of cancer to the peritoneum, the thin lining that covers the abdominal organs and the inside of the abdominal wall. It most often comes from ovarian, colorectal, stomach, appendix and pancreatic cancers. Tumor deposits can cause bloating, fluid buildup (ascites), abdominal pain and bowel blockage. It is a form of advanced cancer, but for selected people, surgery to remove all visible tumor combined with heated chemotherapy (HIPEC) can give long-term control.

Also called: Peritoneal metastases, peritoneal carcinomatosis, carcinomatosis peritonei, peritoneal surface malignancy

At a glance

What it is
Cancer deposits spread across the lining of the abdomen.
Common sources
Ovarian, colorectal, stomach, appendix, pancreatic cancers; rarely primary peritoneal cancer or mesothelioma.
Symptoms
Bloating, swollen abdomen from ascites, pain, early fullness, nausea, weight loss, bowel obstruction.
Diagnosis
CT, MRI or PET scans, fluid testing, laparoscopy and biopsy.
Treatment
Systemic chemotherapy and targeted therapy; cytoreductive surgery with HIPEC for selected people; palliative care.
Outlook
Depends on the primary cancer and extent; much better when complete surgical removal is possible.

When to get help

Call 911 or go to the ER

  • Repeated vomiting, a swollen and hard abdomen, and inability to pass stool or gas (possible bowel obstruction): call 911 or your local emergency number
  • Severe abdominal pain with fever, a rigid belly or signs of shock
  • Severe breathlessness from a tense, swollen abdomen

See a doctor within a day or two

  • A rapidly swelling abdomen or new breathlessness from fluid
  • Unable to eat or drink because of nausea or fullness
  • Fever during chemotherapy

Book a routine appointment

  • Persistent bloating, early fullness or abdominal discomfort lasting more than 3 weeks, especially in women over 50
  • Unexplained weight loss with abdominal symptoms
  • New abdominal symptoms in someone with a history of ovarian, colorectal, stomach or appendix cancer

How cancer spreads to the peritoneum

The peritoneum lines the abdominal cavity and covers the bowel, stomach, liver and other organs. Cancer cells can shed from a tumor that has grown through an organ wall, float in the small amount of fluid in the abdomen, and implant on the peritoneal surfaces. They grow as small nodules or sheets, often on the omentum (a fatty apron hanging from the stomach), the diaphragm and the bowel surface. The deposits can block lymph drainage, causing fluid buildup, and can tether or obstruct the bowel.

Common sources

Primary cancerNotes
Ovarian, fallopian tube and primary peritoneal cancerThe most common cause; often present at diagnosis
Colorectal cancerAbout 1 in 10 people with colorectal cancer develop peritoneal spread
Appendix tumorsCan cause pseudomyxoma peritonei, with jelly-like mucus filling the abdomen
Stomach cancerPeritoneal spread is common in advanced disease
Pancreatic cancerUsually in advanced disease
MesotheliomaPeritoneal mesothelioma arises from the lining itself, often linked to asbestos

Breast and lung cancers occasionally spread to the peritoneum.

Symptoms

Early peritoneal spread may cause no symptoms and is found on scans. As it progresses:

  • bloating and a growing waistline
  • abdominal swelling from fluid (ascites)
  • abdominal pain or discomfort
  • feeling full quickly, loss of appetite
  • nausea and vomiting
  • change in bowel habits, constipation
  • weight loss and fatigue
  • breathlessness when the abdomen is very swollen
  • symptoms of bowel obstruction: cramping pain, vomiting, inability to pass gas or stool

Diagnosis

  1. CT scan of the abdomen and pelvis; small deposits may be missed.
  2. MRI and PET-CT for more detail in some cases.
  3. Tumor markers such as CA-125, CEA and CA 19-9.
  4. Paracentesis: removing ascites fluid with a needle for testing (cytology) and symptom relief.
  5. Diagnostic laparoscopy: keyhole surgery to see the extent of disease and take biopsies. The extent is scored with the Peritoneal Cancer Index (PCI), from 0 to 39, which guides treatment decisions.
  6. Biopsy and molecular testing to guide targeted therapy.

Treatment

Treatment is planned by a specialist multidisciplinary team and depends on the primary cancer, extent of spread, general health and goals.

Systemic therapy

Chemotherapy, targeted therapy and immunotherapy appropriate to the primary cancer are the foundation for most people. For ovarian cancer, combining surgery and chemotherapy is standard and often achieves long remissions.

Cytoreductive surgery and HIPEC

For selected people with limited disease, surgeons remove all visible tumor (cytoreductive surgery), sometimes including the omentum, parts of the bowel and peritoneum. This may be followed by HIPEC (hyperthermic intraperitoneal chemotherapy): heated chemotherapy circulated through the abdomen during surgery for 30 to 90 minutes to kill remaining cells. It is a major operation with significant risks and is done at specialist centers.

Best results are seen in pseudomyxoma peritonei, peritoneal mesothelioma, ovarian cancer and selected colorectal cancers with low PCI scores.

Other approaches

  • PIPAC (pressurized intraperitoneal aerosol chemotherapy) is being studied.
  • Intraperitoneal chemotherapy given through a port in some ovarian cancers.

Symptom and palliative care

  • Paracentesis to drain ascites; an indwelling catheter can allow drainage at home.
  • Managing bowel obstruction: medicines to reduce secretions and nausea, a venting tube, stents or surgery in selected cases.
  • Pain control, nutrition support, and management of nausea.
  • Palliative care teams help with symptoms, emotional support and planning at any stage.

Outlook

Peritoneal carcinomatosis is advanced cancer, and outlook varies widely. Untreated, survival is often measured in months. With modern systemic therapy and, for selected patients, complete cytoreductive surgery with HIPEC, some people live many years, and some with pseudomyxoma peritonei or low-volume disease are long-term survivors. A specialist center can advise on individual options.

Frequently asked questions

What is peritoneal carcinomatosis?

It is cancer that has spread to the peritoneum, the lining of the abdomen. It usually comes from cancers of the ovary, colon, stomach, appendix or pancreas, and can cause bloating, ascites, pain and bowel blockage. It is a form of advanced cancer.

What are the symptoms of peritoneal carcinomatosis?

Common symptoms are bloating, a swollen abdomen from fluid, abdominal pain, feeling full quickly, nausea, weight loss and changes in bowel habits. Vomiting with an inability to pass gas or stool suggests bowel obstruction and needs urgent care.

What is HIPEC?

HIPEC stands for hyperthermic intraperitoneal chemotherapy. After a surgeon removes all visible tumor, heated chemotherapy is circulated inside the abdomen to kill remaining cancer cells. It is used for selected patients at specialist centers and can lead to long-term control.

What is the life expectancy with peritoneal carcinomatosis?

It depends on the type of primary cancer, how widespread the disease is, response to treatment and overall health. Without treatment, survival may be months. With effective chemotherapy and, in selected cases, surgery with HIPEC, some people live for years.

Sources

This guide was written from current patient and clinical guidance, including:

  • National Cancer Institute: Metastatic cancer
  • American Cancer Society: Ovarian cancer and colorectal cancer treatment information
  • Peritoneal Surface Oncology Group International (PSOGI): Consensus statements on cytoreductive surgery and HIPEC
  • National Comprehensive Cancer Network: Guidelines for patients, ovarian and colon cancers
  • MedlinePlus: Ascites